Lisanti Capital Growth, LLC

CIK 0001424467 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-10 · Open the SEC source

Lisanti Capital Growth, LLC reported 109 positions worth $454.6M as of June 30, 2026 (13F filed August 10, 2026). Largest holding: HNGE (2.5%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$454.6M
2026 Q2
Positions
109
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
19.1%
Est. Net Flow (Q)
2026 Q2
10 / 109 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1HNGEHINGE HEALTH INCSH$11.5M2.54%139,150
2BTSGBRIGHTSPRING HEALTH SVCS INCSH$10.8M2.37%154,620
3XMTRXOMETRY INCSH$9.7M2.14%100,880
4SEISOLARIS ENERGY INFRAS INCSH$9.2M2.03%114,745
5CORTCORCEPT THERAPEUTICS INCSH$8.0M1.75%91,610
6DOCNDIGITALOCEAN HLDGS INCSH$7.9M1.74%50,425
7ALGMALLEGRO MICROSYSTEMS INCSH$7.5M1.65%107,865
8MIRMMIRUM PHARMACEUTICALS INCSH$7.4M1.63%63,295
9FROGJFROG LTDSH$7.3M1.61%80,655
10CRSCARPENTER TECHNOLOGY CORPSH$7.2M1.58%11,665

The free plan shows the top 10 positions. The remaining 99 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Lisanti Capital Growth, LLC hold as of Q2 2026?

Lisanti Capital Growth, LLC reported 109 positions worth $454.6M in its Q2 2026 13F filing. Largest positions: HNGE (2.5%), BTSG (2.4%), XMTR (2.1%), SEI (2.0%) and CORT (1.8%).

What did Lisanti Capital Growth, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Lisanti Capital Growth, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.